Business Standard

Page 25 - Pfizer

India capable of strengthening cold chain for Pfizer vaccine: Health secy

Rajesh Bhushan was responding to a query on the country's cold storage capacity for vaccines such as Pfizer's that need to be kept in minus 70 degree celsius

India capable of strengthening cold chain for Pfizer vaccine: Health secy
Updated On : 11 Nov 2020 | 1:51 AM IST

EU plans to buy up to 300 million doses of Pfizer-BioNTech vaccine

Ursula von der Leyen, the president of the EU's executive arm, said the commission will authorize the deal on Wednesday after working tirelessly to secure doses of potential vaccines in recent months

EU plans to buy up to 300 million doses of Pfizer-BioNTech vaccine
Updated On : 11 Nov 2020 | 1:14 AM IST
Updated On : 11 Nov 2020 | 12:03 AM IST

Pfizer Covid-19 vaccine 'very promising' but has cold chain issues: WHO

WHO Director-General Tedros Adhanom Ghebreyesus reiterated the United Nations agency's call for an equitable distribution of vaccine doses once they are available

Pfizer Covid-19 vaccine 'very promising' but has cold chain issues: WHO
Updated On : 10 Nov 2020 | 11:28 PM IST

Coronavirus updates: Pfizer vaccine, 'worst yet to come for US', and more

Brazil has temporarily suspended human testing of the Chinese vaccine Coronavac following a "severe incident"

Coronavirus updates: Pfizer vaccine, 'worst yet to come for US', and more
Updated On : 10 Nov 2020 | 12:11 PM IST

Top headlines: Contradiction in auto sale nos; Pfizer vaccine shows promise

From retail auto sales contradicting robust wholesale numbers to 15th Finance Commission submitting report to President, here are the top headlines

Top headlines: Contradiction in auto sale nos; Pfizer vaccine shows promise
Updated On : 10 Nov 2020 | 12:10 PM IST

Pfizer surges 19% as parent claims Covid-19 vaccine 90% effective

Pfizer and its German partner BioNTech SE said they had so far found no serious safety concerns

Pfizer surges 19% as parent claims Covid-19 vaccine 90% effective
Updated On : 10 Nov 2020 | 10:10 AM IST

Testing timeline: After Pfizer's success what's ahead for Covid vaccines

Pfizer and the maker of the other leading U.S. vaccine candidate have been cautioning for weeks that the earliest they could seek regulatory approval for wider use of their shots would be late Nov

Testing timeline: After Pfizer's success what's ahead for Covid vaccines
Updated On : 10 Nov 2020 | 9:11 AM IST

Trump accuses FDA, Pfizer of withholding Covid vaccine news before polls

The US Food and Drug Administration "and the Democrats didn't want to have me get a Vaccine WIN, prior to the election, so instead it came out five days later - As I've said all along!" Trump said

Trump accuses FDA, Pfizer of withholding Covid vaccine news before polls
Updated On : 10 Nov 2020 | 8:08 AM IST

Behind Pfizer's vaccine, an understated husband-and-wife 'dream team'

Tuereci and Sahin are a "dream team" in that they reconciled their visions with the constraints of reality

Behind Pfizer's vaccine, an understated husband-and-wife 'dream team'
Updated On : 10 Nov 2020 | 8:04 AM IST

Behind Pfizer's Covid vaccine, an understated husband-and-wife 'dream team'

Pfizer and BioNTech are the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine

Behind Pfizer's Covid vaccine, an understated husband-and-wife 'dream team'
Updated On : 10 Nov 2020 | 7:55 AM IST

Oil prices drop as near-term demand concerns overshadow vaccine hopes

U.S. West Texas Intermediate (WTI) crude CLc1 futures dropped 81 cents, or 2%, to $39.48 a barrel

Oil prices drop as near-term demand concerns overshadow vaccine hopes
Updated On : 10 Nov 2020 | 7:50 AM IST

Pfizer coronavirus vaccine results leave questions about safety, longevity

The Pfizer trial started less than four months ago, and how long the vaccine will confer protection and how many will benefit are almost complete unknowns for now

Pfizer coronavirus vaccine results leave questions about safety, longevity
Updated On : 10 Nov 2020 | 7:31 AM IST

Wall Street rallies on first positive data from coronavirus vaccine trial

NEW YORK (Reuters) - The S&P 500 and the Dow rallied sharply but closed shy of their records on Monday as investors bet that a full economic reopening was finally in sight following the first positive data from a late-stage COVID-19 vaccine trial.

Wall Street rallies on first positive data from coronavirus vaccine trial
Updated On : 10 Nov 2020 | 7:27 AM IST

Cautious excitement, relief after Pfizer vaccine result: What happens next?

The vaccine is the first to be tested in the United States to generate late-stage data

Cautious excitement, relief after Pfizer vaccine result: What happens next?
Updated On : 10 Nov 2020 | 7:27 AM IST

Gold plunges 5% over Covid-19 vaccine success as investors dump bullion

Spot prices beat a sharp retreat from a near two-month peak of $1,965.33 hit earlier in the session amid a weaker dollar

Gold plunges 5% over Covid-19 vaccine success as investors dump bullion
Updated On : 10 Nov 2020 | 7:01 AM IST
Updated On : 10 Nov 2020 | 1:35 AM IST

Pfizer's Covid vaccine effectiveness claims inject hope, lift global stocks

Firms hit hardest by restrictions made most gains, with airlines trading 30% higher

Pfizer's Covid vaccine effectiveness claims inject hope, lift global stocks
Updated On : 10 Nov 2020 | 1:08 AM IST

Double-edged news

Pfizer's vaccine is not necessarily great news for India

Double-edged news
Updated On : 09 Nov 2020 | 11:43 PM IST

'Great day for humanity': Pfizer says Covid-19 vaccine over 90% effective

President-elect Joe Biden said the news was excellent but did not change the fact that face masks, social distancing would be needed well into next year

'Great day for humanity': Pfizer says Covid-19 vaccine over 90% effective
Updated On : 09 Nov 2020 | 11:41 PM IST